Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm

Approximately one-third of all newly diagnosed colorectal cancer (CRC) is composed of rectal cancer, with the incidence rising in younger patients. The principal neoadjuvant treatments consist of neoadjuvant short-course radiotherapy and long-course chemoradiation. Locally advanced rectal cancer (LA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Éanna J., Creavin, Ben, Sheahan, Kieran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456909/
https://www.ncbi.nlm.nih.gov/pubmed/32923389
http://dx.doi.org/10.3389/fonc.2020.01369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456909/
https://www.ncbi.nlm.nih.gov/pubmed/32923389
http://dx.doi.org/10.3389/fonc.2020.01369

Ejemplares similares